Gena Pemberton (Clara Bui/Endpoints News)

#Can­nes­Lions2022: Di­ver­si­ty, eq­ui­ty and in­clu­sion takes cen­ter stage as phar­ma in­dus­try is called to ac­tion

CANNES — Di­ver­si­ty, eq­ui­ty and in­clu­sion are not about tick­ing a box or wear­ing a badge, health mar­ket­ing group Om­ni­com Health stressed in a re­cent re­port.

When it comes to in­clu­sion in the phar­ma in­dus­try, “every­one’s got to do the work,” chief DE&I of­fi­cer Gena Pem­ber­ton told End­points News at this year’s Cannes Li­ons fes­ti­val of cre­ativ­i­ty.

Di­ver­si­ty was a key fo­cus at a hand­ful of events in Cannes this year as the phar­ma in­dus­try strug­gles to make mar­ket­ing, drug de­vel­op­ment and clin­i­cal tri­als more in­clu­sive. At IPG’s “Wake Up to Eq­ui­ty” break­fast, the 10th it­er­a­tion of the event, CEO Philippe Krakowsky took a mo­ment to rec­og­nize the in­dus­try’s progress.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.